Survey of oncohematological pharmaceutical care situation in Spain

Objective: To learn about the baseline of Oncohematological Pharmacy Units in Spanish hospitals in order to identify areas for improvement. Method: A survey in line with the objectives set in GEDEFO 2020 Strategic Plan of Pharmaceutical Care for oncohematological patients was designed. The surve...

Full description

Saved in:
Bibliographic Details
Main Authors: María José Martínez-Bautista, Irene Mangues-Bafalluy, Gerardo Cajaraville-Ordoñana, María Josep Carreras-Soler, Ana Clopés-Estela, Estela Moreno-Martínez
Format: Article
Language:English
Published: Elsevier 2019-11-01
Series:Farmacia Hospitalaria
Subjects:
Online Access:http://www.aulamedica.es/fh/pdf/11239.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850180717296746496
author María José Martínez-Bautista
Irene Mangues-Bafalluy
Gerardo Cajaraville-Ordoñana
María Josep Carreras-Soler
Ana Clopés-Estela
Estela Moreno-Martínez
author_facet María José Martínez-Bautista
Irene Mangues-Bafalluy
Gerardo Cajaraville-Ordoñana
María Josep Carreras-Soler
Ana Clopés-Estela
Estela Moreno-Martínez
author_sort María José Martínez-Bautista
collection DOAJ
description Objective: To learn about the baseline of Oncohematological Pharmacy Units in Spanish hospitals in order to identify areas for improvement. Method: A survey in line with the objectives set in GEDEFO 2020 Strategic Plan of Pharmaceutical Care for oncohematological patients was designed. The survey was hosted on GEDEFO’s website during March and April 2017. Activity data for 2016 was collected. Results: A total of 95 hospitals responded to the survey. Out of which, 76% had an integrated information system of pharmacotherapeutic process management, where a variability in technological and organizational processes were found. The oncohematological pharmacist led the implementation of the principles of medicine, based on evidence and results obtained in routine clinical practice. It was shown that 88% of hospitals had standardized protocols. As for safety practices, in 83% of hospitals, oncohematological pharmacists actively participated in the development and maintenance of risk management program, implemented to prevent errors. Preparation was centralized in 89% of hospitals. Variability was observed in pharmaceutical care depending on where the patient was attended. In 92% of hospitals, pharmacists served as reference for Oncohematology, although with different levels of training. Major deficiencies were observed in training programs and teaching. Of all oncohematological pharmacists, 53% had been a researcher over the past three years. Conclusions: These results mark the starting point for Spanish Oncohematological Pharmacy Units to develop strategies for improving the quality of pharmaceutical care offered to oncohematological patients and led by GEDEFO, heads of service, and oncohematological patients themselves.
format Article
id doaj-art-43aabae95e984df19aed2c77f0f79ee7
institution OA Journals
issn 1130-6343
2171-8695
language English
publishDate 2019-11-01
publisher Elsevier
record_format Article
series Farmacia Hospitalaria
spelling doaj-art-43aabae95e984df19aed2c77f0f79ee72025-08-20T02:18:04ZengElsevierFarmacia Hospitalaria1130-63432171-86952019-11-0143619420110.7399/fh.11239Survey of oncohematological pharmaceutical care situation in SpainMaría José Martínez-Bautista0Irene Mangues-Bafalluy1Gerardo Cajaraville-Ordoñana2María Josep Carreras-Soler3Ana Clopés-Estela4Estela Moreno-Martínez5Pharmacy Service, Puerta del Mar University Hospital, Cádiz. SpainPharmacy Service, Arnau de Vilanova Hospital, Lleida. SpainPharmacy Service, Onkologikoa Foundation Hospital, San Sebastián. SpainPharmacy Service, Vall d’Hebron Hospital, Barcelona. SpainInstitut Català d’Oncologia, L’Hospitalet de Llobregat. SpainPharmacy Service, Sant Pau Hospital, Barcelona. SpainObjective: To learn about the baseline of Oncohematological Pharmacy Units in Spanish hospitals in order to identify areas for improvement. Method: A survey in line with the objectives set in GEDEFO 2020 Strategic Plan of Pharmaceutical Care for oncohematological patients was designed. The survey was hosted on GEDEFO’s website during March and April 2017. Activity data for 2016 was collected. Results: A total of 95 hospitals responded to the survey. Out of which, 76% had an integrated information system of pharmacotherapeutic process management, where a variability in technological and organizational processes were found. The oncohematological pharmacist led the implementation of the principles of medicine, based on evidence and results obtained in routine clinical practice. It was shown that 88% of hospitals had standardized protocols. As for safety practices, in 83% of hospitals, oncohematological pharmacists actively participated in the development and maintenance of risk management program, implemented to prevent errors. Preparation was centralized in 89% of hospitals. Variability was observed in pharmaceutical care depending on where the patient was attended. In 92% of hospitals, pharmacists served as reference for Oncohematology, although with different levels of training. Major deficiencies were observed in training programs and teaching. Of all oncohematological pharmacists, 53% had been a researcher over the past three years. Conclusions: These results mark the starting point for Spanish Oncohematological Pharmacy Units to develop strategies for improving the quality of pharmaceutical care offered to oncohematological patients and led by GEDEFO, heads of service, and oncohematological patients themselves.http://www.aulamedica.es/fh/pdf/11239.pdfsurveypharmaceutical carepharmaceutical servicespatient safetyquality healthcare
spellingShingle María José Martínez-Bautista
Irene Mangues-Bafalluy
Gerardo Cajaraville-Ordoñana
María Josep Carreras-Soler
Ana Clopés-Estela
Estela Moreno-Martínez
Survey of oncohematological pharmaceutical care situation in Spain
Farmacia Hospitalaria
survey
pharmaceutical care
pharmaceutical services
patient safety
quality healthcare
title Survey of oncohematological pharmaceutical care situation in Spain
title_full Survey of oncohematological pharmaceutical care situation in Spain
title_fullStr Survey of oncohematological pharmaceutical care situation in Spain
title_full_unstemmed Survey of oncohematological pharmaceutical care situation in Spain
title_short Survey of oncohematological pharmaceutical care situation in Spain
title_sort survey of oncohematological pharmaceutical care situation in spain
topic survey
pharmaceutical care
pharmaceutical services
patient safety
quality healthcare
url http://www.aulamedica.es/fh/pdf/11239.pdf
work_keys_str_mv AT mariajosemartinezbautista surveyofoncohematologicalpharmaceuticalcaresituationinspain
AT irenemanguesbafalluy surveyofoncohematologicalpharmaceuticalcaresituationinspain
AT gerardocajaravilleordonana surveyofoncohematologicalpharmaceuticalcaresituationinspain
AT mariajosepcarrerassoler surveyofoncohematologicalpharmaceuticalcaresituationinspain
AT anaclopesestela surveyofoncohematologicalpharmaceuticalcaresituationinspain
AT estelamorenomartinez surveyofoncohematologicalpharmaceuticalcaresituationinspain